about
Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.Bayesian hierarchical model for transcriptional module discovery by jointly modeling gene expression and ChIP-chip data.Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.Targeted cytosine methylation for in vivo detection of protein-DNA interactions.Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival genePTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer.Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.Mapping chromatin structure in vivo using DNA methyltransferases.Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate CancerGlobal methylation profiles in buccal cells of long-term smokers and moist snuff consumers
P50
Q30418605-375FE204-15CC-40F3-8A49-AB951CEA2CB0Q31121009-F07DB7BA-0B70-4EFE-95D4-A20F85B6ECD8Q34624275-3EDBD99A-2CA8-423F-9CF7-EB2BFA4D5A4CQ35146709-C92E2751-2432-4162-9F37-743F56F13376Q36042066-C6FB7EBF-5F94-466E-8497-FC4C19927C93Q36190648-EB0771F1-FEDF-402A-B2EC-418E9A2EBAFFQ36373503-1A19B21B-F8EF-4663-8B27-CB473A07288DQ36497139-96D860A4-4C60-4234-8DD0-A41BFE51D007Q36570605-A399A0E0-579D-4C8E-884E-9F4020022BADQ36663582-8DAFC4A7-B7C1-4548-B67D-290A880864C0Q40167355-8F5006B7-021B-4F03-8E94-D09D6D79C6EAQ40387762-2B24260B-F090-491C-AC54-C52320E736ACQ46972198-B45D5F24-0A2B-42C5-A04E-0F2DB5493CD4Q47899420-9CBFC597-D4A8-48C2-BC65-59DCA0A634C3Q57239003-E0ADD75F-95B5-4F1A-9ED3-1EC4F6002F8FQ88711396-26679421-BCFC-4D0C-A0C6-5769969C9403
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Walter J Jessen
@ast
Walter J Jessen
@en
Walter J Jessen
@es
Walter J Jessen
@nl
type
label
Walter J Jessen
@ast
Walter J Jessen
@en
Walter J Jessen
@es
Walter J Jessen
@nl
prefLabel
Walter J Jessen
@ast
Walter J Jessen
@en
Walter J Jessen
@es
Walter J Jessen
@nl
P106
P108
P21
P31
P496
0000-0003-3840-4337